|
Chairman, Neoplastic and Autoimmune Diseases Research Institute/Chief Medical Officer Emeritus, IDEC Pharmaceuticals Corporation Antonio J. Grillo-L�pez, M.D. has served as a Director since September 2002. From November 1992 to January 2001, Dr. Grillo-L�pez served as Chief Medical Officer of IDEC Pharmaceuticals Corporation and from January 2001 to November 2003 held the position of Chief Medical Officer Emeritus of IDEC Pharmaceuticals Corporation. Dr. Grillo-L�pez serves on the boards of directors of Favrille, Inc. and Salmedix, Inc., and on the scientific advisory boards of Favrille, Inc., Conforma Therapeutics Corporation, SuperGen, Inc., Salmedix, Inc., Seattle Genetics, Inc., Attenuon LLC and Nereus Pharmaceuticals. Dr. Grillo-L�pez holds a B.S. and an M.D. from the University of Puerto Rico. | 